Healthcare provider profile · identity verified

Matthew A Stetter, DO

Family Practice · MORTON, IL · NPI 1205935848

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	452	115
Rosuvastatin Calcium	Rosuvastatin Calcium	421	102
Losartan Potassium	Losartan Potassium	347	100
Lisinopril	Lisinopril	342	95
Amlodipine Besylate	Amlodipine Besylate	308	80
Atorvastatin Calcium	Atorvastatin Calcium	291	81
Tramadol Hcl	Tramadol Hcl	270	49
Metoprolol Succinate	Metoprolol Succinate	251	66
Gabapentin	Gabapentin	246	57
Metformin Hcl	Metformin Hcl	245	62
Omeprazole	Omeprazole	221	65
Tizanidine Hcl	Tizanidine Hcl	193	45
Montelukast Sodium	Montelukast Sodium	191	55
Pravastatin Sodium	Pravastatin Sodium	184	49
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	182	31
Alprazolam	Alprazolam	166	32
Lorazepam	Lorazepam	161	35
Pantoprazole Sodium	Pantoprazole Sodium	154	34
Simvastatin	Simvastatin	150	40
Meloxicam	Meloxicam	148	49
Tamsulosin Hcl	Tamsulosin Hcl	139	38
Hydrochlorothiazide	Hydrochlorothiazide	137	40
Ezetimibe	Ezetimibe	132	42
Eliquis	Apixaban	125	30
Furosemide	Furosemide	124	37
Metoprolol Tartrate	Metoprolol Tartrate	118	36
Duloxetine Hcl	Duloxetine Hcl	115	29
Escitalopram Oxalate	Escitalopram Oxalate	114	29
Prednisone	Prednisone	113	71
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	29
Trazodone Hcl	Trazodone Hcl	102	29
Zolpidem Tartrate	Zolpidem Tartrate	100	20
Potassium Chloride	Potassium Chloride	99	30
Albuterol Sulfate Hfa	Albuterol Sulfate	95	40
Sertraline Hcl	Sertraline Hcl	90	22
Allopurinol	Allopurinol	89	20
Diclofenac Sodium	Diclofenac Sodium	87	23
Atenolol	Atenolol	86	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	86	24
Amitriptyline Hcl	Amitriptyline Hcl	82	17
Glimepiride	Glimepiride	82	22
Clopidogrel	Clopidogrel Bisulfate	80	20
Finasteride	Finasteride	74	23
Warfarin Sodium	Warfarin Sodium	71	15
Celecoxib	Celecoxib	69	23
Buspirone Hcl	Buspirone Hcl	67	14
Fenofibrate	Fenofibrate	67	19
Pioglitazone Hcl	Pioglitazone Hcl	65	18
Clonazepam	Clonazepam	64	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	64	17
Fluoxetine Hcl	Fluoxetine Hcl	62	15
Famotidine	Famotidine	60	18
Oxybutynin Chloride Er	Oxybutynin Chloride	59	20
Alendronate Sodium	Alendronate Sodium	58	18
Citalopram Hbr	Citalopram Hydrobromide	56	14
Chlorthalidone	Chlorthalidone	55	16
Mirtazapine	Mirtazapine	55	11
Acetaminophen-Codeine	Acetaminophen With Codeine	52	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	51	12
Temazepam	Temazepam	50	suppressed
Donepezil Hcl	Donepezil Hcl	49	suppressed
Azithromycin	Azithromycin	48	38
Jardiance	Empagliflozin	46	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	44	11
Memantine Hcl	Memantine Hcl	43	suppressed
Baclofen	Baclofen	42	12
Carvedilol	Carvedilol	41	13
Ropinirole Hcl	Ropinirole Hcl	41	11
Topiramate	Topiramate	41	12
Xarelto	Rivaroxaban	41	suppressed
Pregabalin	Pregabalin	40	suppressed
Cefdinir	Cefdinir	38	29
Fluticasone Propionate	Fluticasone Propionate	37	17
Bupropion Xl	Bupropion Hcl	36	11
Hydroxyzine Hcl	Hydroxyzine Hcl	36	12
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Testosterone Cypionate	Testosterone Cypionate	36	suppressed
Cephalexin	Cephalexin	34	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	28
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	33	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Propranolol Hcl	Propranolol Hcl	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	30	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	15
Ozempic	Semaglutide	30	suppressed
Klor-Con M20	Potassium Chloride	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Nystatin	Nystatin	29	13
Sucralfate	Sucralfate	28	11
Bumetanide	Bumetanide	27	suppressed
Oxcarbazepine	Oxcarbazepine	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	20
Metformin Hcl Er	Metformin Hcl	25	suppressed
Telmisartan	Telmisartan	25	suppressed
Valsartan	Valsartan	24	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Amoxicillin	Amoxicillin	23	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Levofloxacin	Levofloxacin	21	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Estradiol	Estradiol	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Nabumetone	Nabumetone	18	suppressed
Icosapent Ethyl	Icosapent Ethyl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Colesevelam Hcl	Colesevelam Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Aripiprazole	Aripiprazole	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Myrbetriq	Mirabegron	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Testosterone	Testosterone	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Glipizide	Glipizide	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Naproxen	Naproxen	12	suppressed
Rexulti	Brexpiprazole	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Diazepam	Diazepam	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Linzess	Linaclotide	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Otezla	Apremilast	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error